Immunotherapy of autoimmune disease.
T-cell recognition of autoantigens stands as the primary target for immune intervention in autoimmune disease. Experiments in animal models, in combination with a number of clinical trials completed in the last year, have helped to clarify the pathogenesis of various autoimmune diseases and indicate future strategies for immunotherapy.
Cooke
A
A
Department of Pathology, University of Cambridge, UK.
Wraith
D C
DC
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001324:Autoantigens / Q000276:immunology; D001327:Autoimmune Diseases / Q000628:therapy*; D003888:Desensitization, Immunologic; D006801:Humans; D007167:Immunotherapy; D000922:Immunotoxins / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D001324:Autoantigens; D000922:Immunotoxins